SIRAL1
gene geneOn this page
Also known as SIRalFLJ21103
Summary
SIRAL1 (SIR2 antiphage like 1, HGNC:26110) is a protein-coding gene on chromosome 11q24.2, encoding Protein FAM118B (Q9BPY3). May play a role in Cajal bodies formation.
Enables identical protein binding activity. Predicted to be located in Cajal body.
Source: NCBI Gene 79607 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 49 total
- MANE Select transcript:
NM_024556
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26110 |
| Approved symbol | SIRAL1 |
| Name | SIR2 antiphage like 1 |
| Location | 11q24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SIRal, FLJ21103 |
| Ensembl gene | ENSG00000197798 |
| Ensembl biotype | protein_coding |
| OMIM | 616587 |
| Entrez | 79607 |
Gene structure
Transcript identifiers
Ensembl transcripts: 31 — 28 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000360194, ENST00000525338, ENST00000525728, ENST00000527247, ENST00000528985, ENST00000529731, ENST00000530043, ENST00000531935, ENST00000533050, ENST00000627851, ENST00000891477, ENST00000891478, ENST00000891479, ENST00000891480, ENST00000891481, ENST00000891482, ENST00000891483, ENST00000891484, ENST00000891485, ENST00000891486, ENST00000933494, ENST00000933495, ENST00000933496, ENST00000933497, ENST00000933498, ENST00000933499, ENST00000933500, ENST00000942845, ENST00000942846, ENST00000942847, ENST00000942848
RefSeq mRNA: 2 — MANE Select: NM_024556
NM_001330446, NM_024556
CCDS: CCDS81647, CCDS8470
Canonical transcript exons
ENST00000533050 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000991269 | 126254305 | 126254433 |
| ENSE00000991270 | 126256567 | 126256852 |
| ENSE00000991271 | 126261425 | 126261484 |
| ENSE00001203239 | 126229225 | 126229293 |
| ENSE00002175106 | 126262120 | 126262968 |
| ENSE00002177170 | 126211782 | 126211830 |
| ENSE00003555205 | 126234995 | 126235087 |
| ENSE00003565323 | 126250506 | 126250733 |
| ENSE00003649190 | 126240792 | 126241044 |
Expression profiles
Bgee: expression breadth ubiquitous, 246 present calls, max score 94.16.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.7891 / max 270.0191, expressed in 1797 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 117489 | 15.3111 | 1797 |
| 117488 | 0.4780 | 275 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 94.16 | gold quality |
| secondary oocyte | CL:0000655 | 94.16 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 91.42 | gold quality |
| colonic mucosa | UBERON:0000317 | 91.29 | gold quality |
| rectum | UBERON:0001052 | 90.80 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 90.38 | gold quality |
| cortical plate | UBERON:0005343 | 89.48 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 89.44 | gold quality |
| ileal mucosa | UBERON:0000331 | 89.24 | gold quality |
| heart right ventricle | UBERON:0002080 | 88.65 | gold quality |
| monocyte | CL:0000576 | 88.55 | gold quality |
| nucleus accumbens | UBERON:0001882 | 88.55 | gold quality |
| medial globus pallidus | UBERON:0002477 | 88.53 | gold quality |
| caudate nucleus | UBERON:0001873 | 88.34 | gold quality |
| leukocyte | CL:0000738 | 88.24 | gold quality |
| deltoid | UBERON:0001476 | 88.04 | gold quality |
| gastrocnemius | UBERON:0001388 | 87.88 | gold quality |
| transverse colon | UBERON:0001157 | 87.76 | gold quality |
| muscle of leg | UBERON:0001383 | 87.71 | gold quality |
| putamen | UBERON:0001874 | 87.70 | gold quality |
| islet of Langerhans | UBERON:0000006 | 87.00 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 86.91 | gold quality |
| stromal cell of endometrium | CL:0002255 | 86.75 | gold quality |
| heart left ventricle | UBERON:0002084 | 86.74 | gold quality |
| pancreatic ductal cell | CL:0002079 | 86.63 | silver quality |
| cardiac ventricle | UBERON:0002082 | 86.62 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 86.53 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 86.39 | gold quality |
| large intestine | UBERON:0000059 | 86.37 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.30 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-110499 | no | 195.63 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
77 targeting SIRAL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-3120-5P | 100.00 | 65.56 | 965 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-10523-5P | 99.91 | 69.22 | 2038 |
| HSA-MIR-380-3P | 99.89 | 70.18 | 1978 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-221-5P | 99.86 | 65.45 | 1052 |
| HSA-MIR-8073 | 99.86 | 65.21 | 1118 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-1323 | 99.83 | 69.89 | 2471 |
| HSA-MIR-4495 | 99.82 | 72.08 | 3080 |
| HSA-MIR-548AZ-3P | 99.82 | 70.56 | 3549 |
| HSA-MIR-548BC | 99.82 | 70.61 | 3524 |
| HSA-MIR-548E-3P | 99.82 | 70.59 | 3514 |
| HSA-MIR-548F-3P | 99.82 | 70.59 | 3540 |
Literature-anchored findings (GeneRIF, showing 1)
- YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas. (PMID:33074854)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fam118b | ENSDARG00000078983 |
| mus_musculus | Fam118b | ENSMUSG00000050471 |
| rattus_norvegicus | Fam118b | ENSRNOG00000011543 |
Paralogs (1): FAM118A (ENSG00000100376)
Protein
Protein identifiers
Protein FAM118B — Q9BPY3 (reviewed: Q9BPY3)
All UniProt accessions (6): E9PIM5, E9PMJ2, E9PMW3, G3V179, J3KP39, Q9BPY3
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in Cajal bodies formation.
Subcellular location. Nucleus. Cajal body.
Miscellaneous. Overexpression changes the morphology of Cajal bodies, while depletion disrupts the localization of components of Cajal bodies, reduces splicing capacity and inhibits cell proliferation.
Similarity. Belongs to the FAM118 family.
RefSeq proteins (2): NP_001317375, NP_078832* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR038916 | FAM118 | Family |
Pfam: PF13289
UniProt features (5 total): modified residue 2, initiator methionine 1, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
3 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9R0P | ELECTRON MICROSCOPY | 4.1 |
| 9R3E | ELECTRON MICROSCOPY | 4.8 |
| 9R0S | ELECTRON MICROSCOPY | 5 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BPY3-F1 | 84.66 | 0.64 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 2, 9
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 125 (showing top):
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, TGGNNNNNNKCCAR_UNKNOWN, RASHI_RESPONSE_TO_IONIZING_RADIATION_5, GOCC_CAJAL_BODY, GOCC_NUCLEAR_BODY, GOCC_RIBONUCLEOPROTEIN_GRANULE, chr11q24, CAGTATT_MIR200B_MIR200C_MIR429, KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN, LEE_BMP2_TARGETS_DN, GOCC_SUPRAMOLECULAR_COMPLEX, ESC_J1_UP_EARLY.V1_DN, GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_UP, GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_DN, GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_DN
GO Biological Process (0):
GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (2): Cajal body (GO:0015030), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein binding | 1 |
| binding | 1 |
| nuclear ribonucleoprotein granule | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1127 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SIRAL1 | MAMLD1 | Q13495 | 815 |
| SIRAL1 | ZFTA | C9JLR9 | 808 |
| SIRAL1 | YAP1 | P46937 | 572 |
| SIRAL1 | NUTM1 | Q86Y26 | 451 |
| SIRAL1 | INTS4 | Q96HW7 | 446 |
| SIRAL1 | PRKG1 | P14619 | 435 |
| SIRAL1 | RELA | Q04206 | 411 |
| SIRAL1 | MAML2 | Q8IZL2 | 409 |
| SIRAL1 | EZHIP | Q86X51 | 383 |
| SIRAL1 | TFE3 | P19532 | 368 |
| SIRAL1 | TMEM185B | Q9H7F4 | 360 |
| SIRAL1 | CAMTA1 | Q9Y6Y1 | 356 |
| SIRAL1 | MAML3 | Q96JK9 | 346 |
| SIRAL1 | RHBDD3 | Q9Y3P4 | 332 |
| SIRAL1 | TRMO | Q9BU70 | 320 |
IntAct
101 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| VAPB | FAM83G | psi-mi:“MI:0914”(association) | 0.730 |
| FAM118A | FAM118B | psi-mi:“MI:0915”(physical association) | 0.720 |
| FAM118B | FAM118A | psi-mi:“MI:0915”(physical association) | 0.720 |
| SCN2B | EXOC5 | psi-mi:“MI:0914”(association) | 0.640 |
| TOMM22 | XRCC3 | psi-mi:“MI:0914”(association) | 0.640 |
| FAM118B | SDCBP | psi-mi:“MI:0915”(physical association) | 0.560 |
| SUMO1P1 | FAM118B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SUMO1 | FAM118B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM118B | BAG5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SDCBP | FAM118B | psi-mi:“MI:0915”(physical association) | 0.560 |
| BAG5 | FAM118B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM118B | SUMO1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF8 | FAM118B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM118B | FAM118B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM118B | RAD54L2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PIAS2 | FAM118B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM118B | PDCD10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM174A | BLTP3B | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (101): FAM118B (Two-hybrid), FAM118B (Two-hybrid), FAM118B (Two-hybrid), FAM118B (Two-hybrid), SUMO1P1 (Two-hybrid), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS)
ESM2 similar proteins: A0A0M5K865, A0A0P0VUY4, A0A2H5RJD4, A0A447CCJ8, A0A516F180, A0A516F183, B1Q3J6, B2AFA8, C0SQ89, E9M7A1, F4K493, G4YRT1, G4YUT3, O93248, P0CV73, P15918, P15919, P24271, P26358, P34088, P93002, Q0E0Q3, Q24K09, Q2M3Z7, Q2M3Z8, Q2M405, Q2M408, Q67E00, Q67E01, Q6RX08, Q7Y1I7, Q803H0, Q867B5, Q8AXQ3, Q8BMD7, Q8C569, Q8CBQ5, Q8H6Z4, Q8H6Z6, Q8LPU5
Diamond homologs: Q4QQT2, Q4R836, Q5E977, Q8C569, Q91YN1, Q9BPY3, Q9NWS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
49 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 36 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1635 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:126229333:T:G | donor_gain | 1.0000 |
| 11:126234991:TTAG:T | acceptor_loss | 1.0000 |
| 11:126234992:TA:T | acceptor_loss | 1.0000 |
| 11:126234993:A:AG | acceptor_gain | 1.0000 |
| 11:126234993:A:AT | acceptor_loss | 1.0000 |
| 11:126234994:G:GG | acceptor_gain | 1.0000 |
| 11:126241041:TCCT:T | donor_gain | 1.0000 |
| 11:126241045:G:GG | donor_gain | 1.0000 |
| 11:126250504:A:AG | acceptor_gain | 1.0000 |
| 11:126250505:G:GG | acceptor_gain | 1.0000 |
| 11:126250505:GC:G | acceptor_gain | 1.0000 |
| 11:126250730:AAAG:A | donor_loss | 1.0000 |
| 11:126250731:AAGG:A | donor_loss | 1.0000 |
| 11:126250732:AG:A | donor_loss | 1.0000 |
| 11:126250733:GGTAA:G | donor_loss | 1.0000 |
| 11:126256564:CA:C | acceptor_loss | 1.0000 |
| 11:126256565:A:AC | acceptor_loss | 1.0000 |
| 11:126256565:A:AG | acceptor_gain | 1.0000 |
| 11:126256566:G:GA | acceptor_gain | 1.0000 |
| 11:126256566:GA:G | acceptor_gain | 1.0000 |
| 11:126256566:GAGA:G | acceptor_gain | 1.0000 |
| 11:126256852:GG:G | donor_loss | 1.0000 |
| 11:126256853:G:GA | donor_loss | 1.0000 |
| 11:126256854:T:A | donor_loss | 1.0000 |
| 11:126262119:GGCT:G | acceptor_gain | 1.0000 |
| 11:126229273:G:GT | donor_gain | 0.9900 |
| 11:126231166:T:A | acceptor_gain | 0.9900 |
| 11:126234994:GA:G | acceptor_gain | 0.9900 |
| 11:126234994:GAAA:G | acceptor_gain | 0.9900 |
| 11:126235083:CCCAG:C | donor_loss | 0.9900 |
AlphaMissense
2313 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:126240848:G:A | G48E | 1.000 |
| 11:126240898:T:A | W65R | 1.000 |
| 11:126240898:T:C | W65R | 1.000 |
| 11:126240900:G:C | W65C | 1.000 |
| 11:126240900:G:T | W65C | 1.000 |
| 11:126241016:C:A | A104D | 1.000 |
| 11:126241025:T:C | L107P | 1.000 |
| 11:126250655:T:A | N163K | 1.000 |
| 11:126250655:T:G | N163K | 1.000 |
| 11:126240809:T:C | L35S | 0.999 |
| 11:126240847:G:A | G48R | 0.999 |
| 11:126240847:G:C | G48R | 0.999 |
| 11:126240848:G:T | G48V | 0.999 |
| 11:126240854:G:A | G50D | 0.999 |
| 11:126240859:A:C | S52R | 0.999 |
| 11:126240861:T:A | S52R | 0.999 |
| 11:126240861:T:G | S52R | 0.999 |
| 11:126240899:G:C | W65S | 0.999 |
| 11:126241037:T:C | L111P | 0.999 |
| 11:126250648:C:T | T161I | 0.999 |
| 11:126250659:G:C | D165H | 0.999 |
| 11:126250660:A:C | D165A | 0.999 |
| 11:126250660:A:T | D165V | 0.999 |
| 11:126254314:T:A | W193R | 0.999 |
| 11:126254314:T:C | W193R | 0.999 |
| 11:126254347:C:G | H204D | 0.999 |
| 11:126254357:G:A | G207E | 0.999 |
| 11:126256606:T:C | F246L | 0.999 |
| 11:126256607:T:C | F246S | 0.999 |
| 11:126256608:C:A | F246L | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000001988 (11:126211625 C>T), RS1000037247 (11:126231419 T>C), RS1000108868 (11:126257842 C>A), RS1000176021 (11:126239425 G>A), RS1000207768 (11:126246573 C>G,T), RS1000211101 (11:126250274 G>A), RS1000297544 (11:126217872 T>C), RS1000374053 (11:126244551 C>A), RS1000419633 (11:126253374 G>C,T), RS1000431926 (11:126236862 G>A), RS1000456607 (11:126257366 A>G), RS1000483971 (11:126238139 A>G), RS1000547841 (11:126239780 C>T), RS1000636636 (11:126229487 A>G), RS1000724092 (11:126244213 G>A)
Disease associations
OMIM: gene MIM:616587 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 3 |
| Acetaminophen | increases expression | 2 |
| Hydrogen Peroxide | affects expression, increases expression | 2 |
| dicrotophos | decreases expression | 1 |
| trichostatin A | affects expression | 1 |
| beta-lapachone | increases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| cupric chloride | increases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Bortezomib | increases expression | 1 |
| Air Pollutants, Occupational | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Nickel | decreases expression | 1 |
| Testosterone | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.